- Adolescent chronic unpredictable mild stress induces depression-like behaviours and disrupts the hippocampal miR-34a/SIRT1/BDNF axis, lowering BDNF and increasing miR-34a.
- Fluoxetine reverses CUMS-induced miR-34a elevation and increases hippocampal SIRT1 and BDNF, correlating with restored antidepressant-like behavioural outcomes.
- Ketamine ameliorates behavioural deficits but does not modify hippocampal miR-34a, SIRT1, or BDNF, implying extra-hippocampal mechanisms; miR-34a is a potential biomarker.
Turk Psikiyatri Derg. 2026;37:125-137. doi: 10.5080/u27776.
ABSTRACT
OBJECTIVE: Early life stress is a well-established risk factor for psychiatric disorders in adulthood; however, the underlying molecular mechanisms remain unclear. This study investigated the effects of chronic unpredictable mild stress (CUMS) starting in adolescence on anxiety- and depression-like behaviors, as well as on hippocampal miR- 34a, SIRT1, BDNF, and NLRP3 levels in rats treated with ketamine or fluoxetine.
METHODS: A total of 40 Wistar albino rats (4 weeks old) were divided into four groups: Control, CUMS, CUMS + fluoxetine (FLU), and CUMS + ketamine (KETA). Chronic unpredictable mild stress was applied for 6 weeks, while fluoxetine (10 mg/kg, i.p.) and ketamine (10 mg/kg, i.p.) were administered during the last 3 weeks. Behavioral assessments were performed at weeks 3 and 6 using the sucrose preference test (SPT), open field test (OFT), and forced swim test (FST). Hippocampal BDNF protein levels were measured by ELISA, and miR-34a, SIRT1, and NLRP3 gene expression levels were analyzed by RT-PCR.
RESULTS: Both fluoxetine and ketamine improved CUMS-induced depression-like behaviors. Chronic unpredictable mild stress decreased hippocampal BDNF levels and increased miR-34a expression. Fluoxetine reversed the increase in miR-34a and elevated SIRT1 expression and BDNF levels. In contrast, although ketamine improved behavioral outcomes, it did not significantly alter hippocampal BDNF or SIRT1 levels and did not reduce miR-34a expression. No significant differences in NLRP3 expression were observed among the groups.
CONCLUSION: Adolescent CUMS induces depression-like behaviors by affecting the hippocampal miR-34a/SIRT1/BDNF axis. While the antidepressant effects of fluoxetine are associated with this axis, ketamine may exert its behavioral effects through different and possibly extra-hippocampal mechanisms. miR-34a may serve as a potential biomarker for depression related to early life stress.
PMID:42768876 | DOI:10.5080/u27776
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
